Chardan Capital Stock Ratings and Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Chardan Capital. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Chardan Capital.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
8/16/2018Chardan CapitalInitiateseHealth (EHTH)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/14/2018Chardan CapitalDowngradesSunworks (SUNW)Buy -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
8/13/2018Chardan CapitalReiteratesArrowhead Pharmaceuticals (ARWR)Buy $17.50MediumView Rating Details  Share on Twitter  Share on StockTwits
8/13/2018Chardan CapitalReiteratesDicerna Pharmaceuticals (DRNA)Hold $14.50LowView Rating Details  Share on Twitter  Share on StockTwits
8/13/2018Chardan CapitalReiteratesProQR Therapeutics (PRQR)Buy $9.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/10/2018Chardan CapitalSet Price TargetVuzix (VUZI)Buy $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Chardan CapitalDowngradesGlobalstar (GSAT)Buy -> NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Chardan CapitalReiteratesAdverum Biotechnologies (ADVM)Hold $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Chardan CapitalDowngradesGlobalstar (GSAT)Buy -> Neutral $2.50N/AView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Chardan CapitalLowers TargetRegenxbio (RGNX)Buy$130.00 -> $127.50HighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Chardan CapitalRaises TargetSpark Therapeutics (ONCE)Neutral$60.00 -> $85.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Chardan CapitalReiteratesCrispr Therapeutics (CRSP)Buy $72.50HighView Rating Details  Share on Twitter  Share on StockTwits
8/6/2018Chardan CapitalReiteratesKrystal Biotech (KRYS)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/3/2018Chardan CapitalRaises TargetBenefitfocus (BNFT)Neutral$34.00 -> $36.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/3/2018Chardan CapitalReiteratesAlnylam Pharmaceuticals (ALNY)Buy $180.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/3/2018Chardan CapitalRaises TargetTeladoc (TDOC)Buy$73.00 -> $86.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/3/2018Chardan CapitalRaises TargetEmergent Biosolutions (EBS)Buy$53.00 -> $57.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2018Chardan CapitalReiteratesOphthotech (OPHT)Hold $4.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/31/2018Chardan CapitalDowngradesCastlight Health (CSLT)Buy -> Neutral$6.00 -> $4.80HighView Rating Details  Share on Twitter  Share on StockTwits
7/30/2018Chardan CapitalInitiatesADMA Biologics (ADMA)Buy $10.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/27/2018Chardan CapitalRaises TargetVocera Communications (VCRA)Buy$35.00 -> $47.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/20/2018Chardan CapitalUpgradesEsperion Therapeutics (ESPR)Hold $32.50LowView Rating Details  Share on Twitter  Share on StockTwits
7/16/2018Chardan CapitalRaises TargetRegenxbio (RGNX)Buy -> Buy$90.00 -> $130.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/16/2018Chardan CapitalReiteratesArbutus Biopharma (ABUS)Buy $11.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/10/2018Chardan CapitalRaises TargetRegenxbio (RGNX)Buy -> Buy$90.00 -> $130.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/8/2018Chardan CapitalSet Price TargetArrowhead Pharmaceuticals (ARWR)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/6/2018Chardan CapitalReiteratesIovance Biotherapeutics (IOVA)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/5/2018Chardan CapitalInitiatesDmc Global (BOOM)Buy $59.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/2/2018Chardan CapitalRaises TargetArrowhead Pharmaceuticals (ARWR)Buy$9.50 -> $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/29/2018Chardan CapitalReiteratesVistagen Therapeutics (VTGN)Buy $22.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/28/2018Chardan CapitalInitiatesKrystal Biotech (KRYS)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/25/2018Chardan CapitalInitiatesAudentes Therapeutics (BOLD)Neutral $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/24/2018Chardan CapitalReiteratesSolid Biosciences (SLDB)Buy $60.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/21/2018Chardan CapitalReiteratesVoyager Therapeutics (VYGR)Hold $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/19/2018Chardan CapitalReiteratesCatalyst Biosciences (CBIO)Buy $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/18/2018Chardan CapitalReiteratesLa Jolla Pharmaceutical (LJPC)Buy $115.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/15/2018Chardan CapitalInitiatesContraFect (CFRX)Buy $2.80HighView Rating Details  Share on Twitter  Share on StockTwits
6/13/2018Chardan CapitalReiteratesOphthotech (OPHT)Hold $4.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/6/2018Chardan CapitalReiteratesAxovant Sciences (AXON)Hold $4.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/6/2018Chardan CapitalReiteratesNightstar Therapeutics (NITE)Buy $40.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/4/2018Chardan CapitalUpgradesTivity Health (TVTY)Neutral -> Buy $42.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/18/2018Chardan CapitalRaises TargetTabula Rasa HealthCare (TRHC)Buy$50.00 -> $68.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018Chardan CapitalRaises TargetCrispr Therapeutics (CRSP)Buy$25.00 -> $72.50MediumView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018Chardan CapitalLowers TargetEditas Medicine (EDIT)Buy$72.50 -> $55.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018Chardan CapitalUpgradesIntellia Therapeutics (NTLA)Neutral -> BuyHighView Rating Details  Share on Twitter  Share on StockTwits
5/11/2018Chardan CapitalRaises TargetCastlight Health (CSLT)Buy -> Buy$5.75 -> $6.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Chardan CapitalReiteratesSolid Biosciences (SLDB)Buy $37.50LowView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018Chardan CapitalReiteratesArbutus Biopharma (ABUS)Buy $8.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/5/2018Chardan CapitalReiteratesMedical Transcription Billing (MTBC)Buy -> Buy $2.75HighView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018Chardan CapitalRaises TargetBenefitfocus (BNFT)Neutral -> Neutral$27.00 -> $34.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/30/2018Chardan CapitalReiteratesUniqure (QURE)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
4/23/2018Chardan CapitalDowngradesSpark Therapeutics (ONCE)Buy -> Neutral$80.00 -> $85.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/13/2018Chardan CapitalDowngradesAveXis (AVXS)Buy -> NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
4/13/2018Chardan CapitalDowngradesAssembly Biosciences (ASMB)Buy -> Neutral$35.00 -> $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/9/2018Chardan CapitalRaises TargetRegenxbio (RGNX)Buy -> Buy$85.00 -> $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/9/2018Chardan CapitalInitiatesDarioHealth (DRIO)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Chardan CapitalReiteratesSocial Reality (SRAX)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
4/5/2018Chardan CapitalInitiatesProQR Therapeutics (PRQR)Buy $4.50LowView Rating Details  Share on Twitter  Share on StockTwits
3/27/2018Chardan CapitalRaises TargetEsperion Therapeutics (ESPR)Neutral -> Neutral$75.00 -> $100.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/23/2018Chardan CapitalRaises TargetCaladrius Biosciences (CLBS)Buy -> Buy$6.50 -> $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018Chardan CapitalReiteratesAralez Pharmaceuticals (ARLZ)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018Chardan CapitalRaises TargetHealthequity (HQY)Buy -> Buy$62.00 -> $77.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/19/2018Chardan CapitalInitiatesArbutus Biopharma (ABUS)Buy -> Buy $8.25HighView Rating Details  Share on Twitter  Share on StockTwits
3/16/2018Chardan CapitalReiteratesTabula Rasa HealthCare (TRHC)Buy -> Buy$46.00 -> $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018Chardan CapitalLowers TargetBenefitfocus (BNFT)Neutral -> Neutral$28.00 -> $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/9/2018Chardan CapitalInitiatesDicerna Pharmaceuticals (DRNA)Neutral -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Chardan CapitalDowngradesVascular Biogenics (VBLT)Buy -> Neutral$25.00 -> $3.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/4/2018Chardan CapitalReiteratesORBCOMM (ORBC)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018Chardan CapitalReiteratesNovavax (NVAX)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
2/28/2018Chardan CapitalReiteratesTeladoc (TDOC)Buy -> Buy$48.00 -> $47.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2018Chardan CapitalSet Price TargetCogint (COGT)Buy $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/23/2018Chardan CapitalReiteratesTivity Health (TVTY)Neutral -> Neutral$44.00 -> $41.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/22/2018Chardan CapitalReiteratesCastlight Health (CSLT)Buy -> Buy$6.30 -> $5.75LowView Rating Details  Share on Twitter  Share on StockTwits
2/21/2018Chardan CapitalReiteratesNice (NICE)Neutral -> Neutral$91.00 -> $99.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/21/2018Chardan CapitalInitiatesSolid Biosciences (SLDB)Buy -> Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/19/2018Chardan CapitalReiteratesArrowhead Pharmaceuticals (ARWR)Buy $7.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/12/2018Chardan CapitalReiteratesVocera Communications (VCRA)Buy -> Buy$37.00 -> $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Chardan CapitalRaises TargetCatalyst Biosciences (CBIO)Buy -> Buy$10.00 -> $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/8/2018Chardan CapitalLowers TargetVistagen Therapeutics (VTGN)Buy -> Buy$30.00 -> $22.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/2/2018Chardan CapitalInitiatesKamada (KMDA)Buy -> Buy $7.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/30/2018Chardan CapitalInitiatesVocera Communications (VCRA)Buy -> Buy $37.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/26/2018Chardan CapitalReiterates22nd Century Group (XXII)Buy -> Buy $11.50N/AView Rating Details  Share on Twitter  Share on StockTwits
1/25/2018Chardan CapitalRaises TargetLa Jolla Pharmaceutical (LJPC)Neutral -> Buy$90.00 -> $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/24/2018Chardan CapitalReiteratesThe Medicines (MDCO)Buy $85.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/22/2018Chardan CapitalInitiatesArthroCare (ARTC)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
1/22/2018Chardan CapitalReiteratesIovance Biotherapeutics (IOVA)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
1/22/2018Chardan CapitalInitiatesArcturus Therapeutics (ARCT)Buy -> Buy $12.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/16/2018Chardan CapitalReiteratesRegulus Therapeutics (RGLS)NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
1/16/2018Chardan CapitalReiteratesProQR Therapeutics (PRQR)NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
1/16/2018Chardan CapitalReiteratesMiragen Therapeutics (MGEN)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
1/16/2018Chardan CapitalReiteratesDicerna Pharmaceuticals (DRNA)NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
1/16/2018Chardan CapitalReiteratesArrowhead Pharmaceuticals (ARWR)NeutralMediumView Rating Details  Share on Twitter  Share on StockTwits
1/16/2018Chardan CapitalReiteratesArbutus Biopharma (ABUS)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
1/19/2018Chardan CapitalReiteratesAlnylam Pharmaceuticals (ALNY)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
1/16/2018Chardan CapitalRaises TargetEmergent Biosolutions (EBS)Buy$47.00 -> $53.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/10/2018Chardan CapitalReiteratesChildrens Place (PLCE)Buy -> Buy$130.00 -> $156.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/10/2018Chardan CapitalUpgradesAxovant Sciences (AXON)Sell -> Neutral$2.50 -> $2.50LowView Rating Details  Share on Twitter  Share on StockTwits
1/8/2018Chardan CapitalUpgradesCaesarstone (CSTE)Neutral -> Buy $32.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/8/2018Chardan CapitalUpgradesStratus Properties (STRS)Neutral -> BuyHighView Rating Details  Share on Twitter  Share on StockTwits
1/5/2018Chardan CapitalReiteratesAveXis (AVXS)Buy $135.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/3/2018Chardan CapitalInitiatesNightstar Therapeutics (NITE)Buy -> Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/3/2018Chardan CapitalDowngradesKEYW (KEYW)Buy -> NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
1/1/2018Chardan CapitalSet Price TargetVuzix (VUZI)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/26/2017Chardan CapitalSet Price TargetVuzix (VUZI)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/22/2017Chardan CapitalReiteratesLa Jolla Pharmaceutical (LJPC)Buy $90.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/22/2017Chardan CapitalReiteratesDimension Therapeutics (DMTX)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
12/19/2017Chardan CapitalReiteratesAdverum Biotechnologies (ADVM)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
12/12/2017Chardan CapitalLowers TargetSpark Therapeutics (ONCE)Buy -> Buy$100.00 -> $60.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/11/2017Chardan CapitalReiteratesRegenxbio (RGNX)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
12/6/2017Chardan CapitalRaises TargetHealthequity (HQY)Buy -> Buy$58.00 -> $62.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/6/2017Chardan CapitalRaises TargetEsperion Therapeutics (ESPR)Neutral$20.00 -> $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/5/2017Chardan CapitalReiteratesEsperion Therapeutics (ESPR)Neutral -> Neutral$20.00 -> $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/17/2017Chardan CapitalDowngradesIturan Location and Control Ltd. (US) (ITRN)Buy -> Neutral $36.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/14/2017Chardan CapitalReiteratesBiocept (BIOC)Buy -> Buy$2.50 -> $1.50N/AView Rating Details  Share on Twitter  Share on StockTwits
11/14/2017Chardan CapitalRaises TargetMedical Transcription Billing (MTBC)Buy -> Buy$2.25 -> $2.75N/AView Rating Details  Share on Twitter  Share on StockTwits
11/10/2017Chardan CapitalUpgradesSAGE Therapeutics (SAGE)Neutral -> Buy$60.00 -> $140.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/10/2017Chardan CapitalRaises TargetProfire Energy (PFIE)Buy$2.30 -> $2.50N/AView Rating Details  Share on Twitter  Share on StockTwits
11/9/2017Chardan CapitalRaises TargetRegenxbio (RGNX)Buy -> Buy$75.00 -> $85.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/9/2017Chardan CapitalReiteratesCogint (COGT)Buy -> Buy$12.50 -> $7.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017Chardan CapitalReiteratesCaesarstone (CSTE)Neutral -> Neutral$43.00 -> $32.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/6/2017Chardan CapitalReiteratesSpring Bank Pharmaceuticals (SBPH)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/6/2017Chardan CapitalRaises TargetVascular Biogenics (VBLT)Buy -> Buy$20.00 -> $25.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/6/2017Chardan CapitalDowngradesNice (NICE)Buy -> Neutral $91.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/3/2017Chardan CapitalReiteratesAxovant Sciences (AXON)Sell $3.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2017Chardan CapitalReiteratesAveXis (AVXS)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
10/31/2017Chardan CapitalReiteratesVoyager Therapeutics (VYGR)Hold $17.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/27/2017Chardan CapitalReiteratesTivity Health (TVTY)Neutral -> Neutral$40.00 -> $44.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/26/2017Chardan CapitalLowers TargetCastlight Health (CSLT)Buy$6.50 -> $6.30N/AView Rating Details  Share on Twitter  Share on StockTwits
10/16/2017Chardan CapitalRaises Target22nd Century Group (XXII)Buy$3.50 -> $11.50N/AView Rating Details  Share on Twitter  Share on StockTwits
10/16/2017Chardan CapitalRaises TargetNice (NICE)Buy -> Buy$84.00 -> $91.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/16/2017Chardan CapitalReiteratesMiragen Therapeutics (MGEN)Buy $29.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/13/2017Chardan CapitalReiteratesSpark Therapeutics (ONCE)Buy $100.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/6/2017Chardan CapitalReiteratesAxovant Sciences (AXON)Sell $3.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/1/2017Chardan CapitalReiteratesBioSig Technologies (BSGM)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
10/5/2017Chardan CapitalReiteratesAmicus Therapeutics (FOLD)Buy$16.50 -> $18.50N/AView Rating Details  Share on Twitter  Share on StockTwits
10/2/2017Chardan CapitalUpgradesSunworks (SUNW)Neutral -> Buy $2.50HighView Rating Details  Share on Twitter  Share on StockTwits
9/26/2017Chardan CapitalReiteratesSocial Reality (SRAX)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
9/25/2017Chardan CapitalReiteratesAlnylam Pharmaceuticals (ALNY)Buy $124.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/23/2017Chardan CapitalReiteratesAxovant Sciences (AXON)Sell -> Sell $3.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/20/2017Chardan CapitalReiteratesThe Medicines (MDCO)Buy $85.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/17/2017Chardan CapitalReiteratesSpring Bank Pharmaceuticals (SBPH)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
9/17/2017Chardan CapitalReiteratesProQR Therapeutics (PRQR)NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
9/17/2017Chardan CapitalReiteratesAssembly Biosciences (ASMB)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
9/17/2017Chardan CapitalReiteratesAkari Therapeutics (AKTX)NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
9/17/2017Chardan CapitalReiteratesAchillion Pharmaceuticals (ACHN)NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
9/13/2017Chardan CapitalReiteratesArrowhead Pharmaceuticals (ARWR)NeutralMediumView Rating Details  Share on Twitter  Share on StockTwits
9/13/2017Chardan CapitalReiteratesArbutus Biopharma (ABUS)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
9/14/2017Chardan CapitalReiteratesAxovant Sciences (AXON)Sell $8.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/13/2017Chardan CapitalReiteratesAmicus Therapeutics (FOLD)Buy -> Buy$17.50 -> $16.50LowView Rating Details  Share on Twitter  Share on StockTwits
9/13/2017Chardan CapitalReiteratesSAGE Therapeutics (SAGE)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
9/7/2017Chardan CapitalReiteratesIovance Biotherapeutics (IOVA)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
9/10/2017Chardan CapitalReiteratesVoyager Therapeutics (VYGR)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
9/11/2017Chardan CapitalReiteratesAlnylam Pharmaceuticals (ALNY)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
9/5/2017Chardan CapitalReiteratesRegenxbio (RGNX)Buy$55.00 -> $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/5/2017Chardan CapitalReiteratesAdverum Biotechnologies (ADVM)Hold $3.50HighView Rating Details  Share on Twitter  Share on StockTwits
9/1/2017Chardan CapitalReiteratesIovance Biotherapeutics (IOVA)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/29/2017Chardan CapitalReiteratesThe Medicines (MDCO)Buy -> Buy$80.00 -> $85.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/29/2017Chardan CapitalInitiatesTivity Health (TVTY)Neutral $40.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/29/2017Chardan CapitalDowngradesIntellia Therapeutics (NTLA)Buy -> Neutral $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/14/2017Chardan CapitalReiteratesDicerna Pharmaceuticals (DRNA)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
8/14/2017Chardan CapitalReiteratesCrispr Therapeutics (CRSP)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
8/14/2017Chardan CapitalReiteratesMiragen Therapeutics (MGEN)Buy$26.00 -> $29.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/14/2017Chardan CapitalReiteratesDimension Therapeutics (DMTX)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
8/14/2017Chardan CapitalInitiatesFORESIGHT AUTON/S (FRSX)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/7/2017Chardan CapitalReiteratesMiragen Therapeutics (MGEN)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
8/11/2017Chardan CapitalReiteratesAkari Therapeutics (AKTX)Neutral$6.00 -> $2.50LowView Rating Details  Share on Twitter  Share on StockTwits
8/11/2017Chardan CapitalReiteratesAveXis (AVXS)Buy -> Buy$102.50 -> $130.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/10/2017Chardan CapitalReiteratesAlnylam Pharmaceuticals (ALNY)Buy$131.00 -> $124.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/10/2017Chardan CapitalRaises TargetAmicus Therapeutics (FOLD)Buy -> Buy$12.50 -> $17.50HighView Rating Details  Share on Twitter  Share on StockTwits
8/10/2017Chardan CapitalLowers TargetAralez Pharmaceuticals (ARLZ)Buy -> Buy$5.50 -> $4.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/9/2017Chardan CapitalLowers TargetAchillion Pharmaceuticals (ACHN)Neutral$5.00 -> $4.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/9/2017Chardan CapitalRaises TargetRegenxbio (RGNX)Buy$50.00 -> $55.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2017Chardan CapitalUpgradesSpark Therapeutics (ONCE)Neutral -> Buy$60.00 -> $100.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/8/2017Chardan CapitalLowers TargetRitter Pharmaceuticals (RTTR)Buy -> Buy$35.00 -> $15.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/8/2017Chardan CapitalReiteratesLa Jolla Pharmaceutical (LJPC)Buy $85.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/8/2017Chardan CapitalRaises TargetTabula Rasa HealthCare (TRHC)Buy -> Buy$19.50 -> $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/7/2017Chardan CapitalReiteratesArbutus Biopharma (ABUS)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
8/7/2017Chardan CapitalRaises TargetNice (NICE)Buy -> Buy$76.00 -> $84.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/4/2017Chardan CapitalDowngradesBenefitfocus (BNFT)Buy -> Neutral$36.00 -> $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/2/2017Chardan CapitalReiteratesIntellia Therapeutics (NTLA)Buy$19.00 -> $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/2/2017Chardan CapitalUpgradesSpark Therapeutics (ONCE)Neutral -> Buy$60.00 -> $100.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/2/2017Chardan CapitalDowngradesRegulus Therapeutics (RGLS)Buy -> NeutralLowView Rating Details  Share on Twitter  Share on StockTwits
8/1/2017Chardan CapitalLowers TargetSpring Bank Pharmaceuticals (SBPH)Buy -> Buy$34.00 -> $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/27/2017Chardan CapitalReiteratesNovavax (NVAX)Neutral $1.50LowView Rating Details  Share on Twitter  Share on StockTwits
7/25/2017Chardan CapitalReiteratesMiragen Therapeutics (MGEN)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/23/2017Chardan CapitalSet Price TargetUniqure (QURE)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/24/2017Chardan CapitalReiteratesSpark Therapeutics (ONCE)Hold -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
7/17/2017Chardan CapitalLowers TargetSocial Reality (SRAX)Buy$9.00 -> $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
7/17/2017Chardan CapitalReiteratesSocial Reality (SRAX)Buy -> Buy$9.00 -> $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/10/2017Chardan CapitalReiteratesAlnylam Pharmaceuticals (ALNY)Buy$110.00 -> $131.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/10/2017Chardan CapitalInitiatesTabula Rasa HealthCare (TRHC)Buy -> Buy $19.50LowView Rating Details  Share on Twitter  Share on StockTwits
6/23/2017Chardan CapitalInitiatesAntares Pharma (ATRS)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/20/2017Chardan CapitalRaises TargetTeladoc (TDOC)Buy -> Buy$30.00 -> $41.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/18/2017Chardan CapitalSet Price TargetAveXis (AVXS)Buy $103.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/19/2017Chardan CapitalUpgradesClovis Oncology (CLVS)Sell -> Neutral$36.00 -> $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/12/2017Chardan CapitalSet Price TargetAlnylam Pharmaceuticals (ALNY)Buy $110.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/13/2017Chardan CapitalLowers TargetRegulus Therapeutics (RGLS)Buy -> Buy$5.00 -> $2.50MediumView Rating Details  Share on Twitter  Share on StockTwits
6/12/2017Chardan CapitalInitiatesCatalyst Biosciences (CBIO)Buy -> Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/7/2017Chardan CapitalRaises TargetHealthequity (HQY)Buy -> Buy$53.00 -> $57.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/6/2017Chardan CapitalInitiatesCastlight Health (CSLT)Buy $4.50MediumView Rating Details  Share on Twitter  Share on StockTwits
6/1/2017Chardan CapitalReiteratesAmicus Therapeutics (FOLD)Buy $12.50MediumView Rating Details  Share on Twitter  Share on StockTwits
5/31/2017Chardan CapitalUpgradesAkari Therapeutics (AKTX)Sell -> Neutral$6.50 -> $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/30/2017Chardan CapitalInitiatesAssembly Biosciences (ASMB)Buy -> Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/24/2017Chardan CapitalRaises TargetSpring Bank Pharmaceuticals (SBPH)Buy -> Buy$16.50 -> $34.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/22/2017Chardan CapitalSet Price TargetLa Jolla Pharmaceutical (LJPC)Buy $34.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/23/2017Chardan CapitalRaises TargetOncoCyte (OCX)Buy$6.50 -> $7.75N/AView Rating Details  Share on Twitter  Share on StockTwits
5/23/2017Chardan CapitalReiteratesOncoCyte (OCX)Buy -> Buy$6.50 -> $7.75HighView Rating Details  Share on Twitter  Share on StockTwits
5/17/2017Chardan CapitalReiteratesAralez Pharmaceuticals (ARZ)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
5/17/2017Chardan CapitalReiteratesIovance Biotherapeutics (IOVA)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
5/19/2017Chardan CapitalInitiatesModel N (MODN)Buy -> Buy $16.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/17/2017Chardan CapitalReiteratesGenius Brands International (GNUS)Buy -> Buy$10.50 -> $8.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/15/2017Chardan CapitalRaises TargetMedical Transcription Billing (MTBC)Buy$1.85 -> $2.25MediumView Rating Details  Share on Twitter  Share on StockTwits
5/15/2017Chardan CapitalLowers TargetAlnylam Pharmaceuticals (ALNY)Buy$110.00 -> $95.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/11/2017Chardan CapitalDowngradesCaesarstone (CSTE)Buy -> Neutral$39.00 -> $43.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/9/2017Chardan CapitalRaises TargetTeladoc (TDOC)Buy -> Buy$28.00 -> $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/5/2017Chardan CapitalSet Price TargetAlnylam Pharmaceuticals (ALNY)Buy$97.00 -> $95.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/5/2017Chardan CapitalInitiatesElbit Systems (ESLT)Neutral -> Neutral $110.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/4/2017Chardan CapitalRaises TargetIovance Biotherapeutics (IOVA)Buy -> Buy$18.00 -> $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2017Chardan CapitalInitiatesSpring Bank Pharmaceuticals (SBPH)Buy -> Buy $16.50HighView Rating Details  Share on Twitter  Share on StockTwits
4/28/2017Chardan CapitalRaises TargetBenefitfocus (BNFT)Buy -> Buy$31.00 -> $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/25/2017Chardan CapitalReiteratesAkari Therapeutics (AKTX)Sell $6.50HighView Rating Details  Share on Twitter  Share on StockTwits
4/17/2017Chardan CapitalReiteratesIovance Biotherapeutics (IOVA)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
4/17/2017Chardan CapitalLowers TargetAkari Therapeutics (AKTX)Sell -> Sell$6.50 -> $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/12/2017Chardan CapitalReiteratesGlobalstar (GSAT)Buy $2.50LowView Rating Details  Share on Twitter  Share on StockTwits
4/11/2017Chardan CapitalRaises TargetRegenxbio (RGNX)Buy -> Buy$35.00 -> $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/4/2017Chardan CapitalUpgradesArbutus Biopharma (ABUS)Neutral -> Buy$3.00 -> $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/30/2017Chardan CapitalLowers TargetRitter Pharmaceuticals (RTTR)Buy -> Buy$45.00 -> $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/27/2017Chardan CapitalInitiatesIntellia Therapeutics (NTLA)Buy -> Buy $19.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/27/2017Chardan CapitalInitiatesEditas Medicine (EDIT)Buy -> BuyHighView Rating Details  Share on Twitter  Share on StockTwits
3/27/2017Chardan CapitalInitiatesCrispr Therapeutics (CRSP)Buy -> Buy $23.50HighView Rating Details  Share on Twitter  Share on StockTwits
3/27/2017Chardan CapitalReiteratesTeladoc (TDOC)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
3/21/2017Chardan CapitalReiteratesMassRoots (MSRT)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
3/21/2017Chardan CapitalReiteratesGenius Brands International (GNUS)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
3/21/2017Chardan CapitalReiteratesDelta Galil Industries (DELTY)NeutralN/AView Rating Details  Share on Twitter  Share on StockTwits
3/22/2017Chardan CapitalReiteratesHealthequity (HQY)Buy -> Buy$50.00 -> $53.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/17/2017Chardan CapitalReiteratesAveXis (AVXS)Buy $100.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/17/2017Chardan CapitalSet Price TargetVuzix (VUZI)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/16/2017Chardan CapitalReiteratesClovis Oncology (CLVS)Sell $36.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/16/2017Chardan CapitalReiteratesVoyager Therapeutics (VYGR)Neutral -> Neutral $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/15/2017Chardan CapitalReiteratesBenefitfocus (BNFT)Buy $31.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/15/2017Chardan CapitalLowers TargetAralez Pharmaceuticals (ARLZ)Buy -> Buy$10.00 -> $5.50HighView Rating Details  Share on Twitter  Share on StockTwits
3/13/2017Chardan CapitalDowngradesSunworks (SUNW)Buy -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
3/13/2017Chardan CapitalReiteratesCogint (COGT)Buy $12.50MediumView Rating Details  Share on Twitter  Share on StockTwits
3/13/2017Chardan CapitalReiteratesProfire Energy (PFIE)Buy -> Buy$2.00 -> $2.15HighView Rating Details  Share on Twitter  Share on StockTwits
3/8/2017Chardan CapitalLowers TargetAlliqua Biomedical (ALQA)Buy -> Buy$20.00 -> $12.50HighView Rating Details  Share on Twitter  Share on StockTwits
3/7/2017Chardan CapitalReiterates22nd Century Group (XXII)Buy $3.50N/AView Rating Details  Share on Twitter  Share on StockTwits
3/7/2017Chardan CapitalReiteratesVuzix (VUZI)Buy $10.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/2/2017Chardan CapitalRaises TargetTeladoc (TDOC)Buy -> Buy$24.00 -> $28.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/2/2017Chardan CapitalReiteratesORBCOMM (ORBC)Buy $11.50N/AView Rating Details  Share on Twitter  Share on StockTwits
3/2/2017Chardan CapitalRaises TargetLa Jolla Pharmaceutical (LJPC)Buy$80.00 -> $90.00N/AView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Friday at 03:05 AM ET.

MarketBeat Community Rating for Chardan Capital

Community Ranking:  0.1 out of 5 (star star star)
Outperform Votes:  357 (Vote Outperform)
Underperform Votes:  12,095 (Vote Underperform)
Total Votes:  12,452
MarketBeat's community ratings are surveys of what our community members think about Chardan Capital and other research firms. Vote "Outperform" if you believe Chardan Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Chardan Capital's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.